BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37982910)

  • 1. Hypoxia-induced circRTN4IP1 promotes progression and glycolysis of hepatocellular carcinoma cells.
    Yang X; Lou C; Zhang Q; Liu G; Ding Y; Zhang Q; Ye C
    Funct Integr Genomics; 2023 Nov; 23(4):339. PubMed ID: 37982910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production.
    Tang J; Wang R; Tang R; Gu P; Han J; Huang W
    Pathol Res Pract; 2022 Feb; 230():153732. PubMed ID: 34974242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p.
    Zhou Y; Huang Y; Hu K; Zhang Z; Yang J; Wang Z
    Cell Death Dis; 2020 Mar; 11(3):176. PubMed ID: 32152275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
    Liu W; Yin C; Liu Y
    Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
    [No Abstract]   [Full Text] [Related]  

  • 5. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
    Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
    Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia.
    Hu M; Fu Q; Jing C; Zhang X; Qin T; Pan Y
    Biomed Pharmacother; 2020 May; 125():109703. PubMed ID: 32062551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 9. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia.
    Fang X; Bai Y; Zhang L; Ding S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0001806 promotes glycolysis and cell progression in hepatocellular carcinoma through miR-125b/HK2.
    Chen X; She P; Wang C; Shi L; Zhang T; Wang Y; Li H; Qian L; Li M
    J Clin Lab Anal; 2021 Dec; 35(12):e23991. PubMed ID: 34664737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA Circ-CCND1 Aggravates Hepatocellular Carcinoma Tumorigenesis by Regulating the miR-497-5p/HMGA2 Axis.
    Zheng S; Hou J; Chang Y; Zhao D; Yang H; Yang J
    Mol Biotechnol; 2022 Feb; 64(2):178-186. PubMed ID: 34564768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p/ALX4 axis.
    Xu Q; Zhou L; Yang G; Meng F; Wan Y; Wang L; Zhang L
    Biotechnol Lett; 2020 Dec; 42(12):2735-2747. PubMed ID: 32856218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-mediated circTTLL5 transfer promotes hepatocellular carcinoma malignant progression through miR-136-5p/KIAA1522 axis.
    Liu C; Ren C; Guo L; Yang C; Yu Q
    Pathol Res Pract; 2023 Jan; 241():154276. PubMed ID: 36528986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122-5p/CTNND2 axis.
    Yang X; Yao B; Niu Y; Chen T; Mo H; Wang L; Guo C; Yao D
    Biochem Biophys Res Commun; 2019 Oct; 518(2):239-245. PubMed ID: 31421822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis.
    Maimaiti Y; Kamali A; Yang P; Zhong K; Abuduhadeer X
    Protein Pept Lett; 2022; 29(7):595-604. PubMed ID: 35899951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
    Yang X; Liu L; Zou H; Zheng YW; Wang KP
    Dig Liver Dis; 2019 Oct; 51(10):1446-1455. PubMed ID: 31147216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.